Palatin Technologies
Palatin Technologies reported revenue of $9 million in fiscal 2026. Its operating margin was −98.2%. Free cash flow was −$14 million. The diluted share count rose 425.2%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Income statement
From fiscal 2017 to 2019, earnings per share grew 0.0% a year and net income 20.4% a year, as new shares raised the share count by 5% and diluted each share's earnings. Palatin Technologies then lost money in fiscal 2020, 2021, 2022, 2023, 2024, 2025 and 2026.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | 30 | 14 | 10 | 3 | 8 |
| Debt incl. finance leases | — | — | — | — | — |
| Net debt (negative means net cash) | — | — | — | — | — |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | — | — | — | — | — |
| Interest coverage | −1,232.7x | −1,621.9x | −1,314.5x | −1,162.1x | −1,288.8x |
| Current ratio | 2.1x | 1.1x | 1.0x | 0.4x | 4.6x |
| Quick ratio | 2.1x | 1.0x | 1.0x | 0.4x | 4.6x |
Cash flow
Projections
Project Palatin Technologies' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, no insider bought Palatin Technologies shares on the open market, and 1 insider sold $9,458, all of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Dec 24, 2025 | Stephen T WillsExecutive VP and CFO/COO | Sold plan | 565 | $16.74 | $9,458 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY24 | FY25 | FY26 |
|---|---|---|---|
| Piotroski F-score | — | — | — |
| Rule of 40 | −709.1% | — | — |
| Altman Z'' | −148.08 | −504.86 | −176.87 |
| Accruals ratio | 12.0% | 57.1% | 87.5% |
The nine F-score tests
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Fail |
| Cash from operations is positive | Fail | Fail | Fail |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Fail | Fail | Fail |
| Debt fell relative to assets | — | — | — |
| Current ratio rose | Fail | Fail | Pass |
| Share count didn't rise | Fail | Pass | Fail |
| Gross margin rose | Pass | — | — |
| Revenue rose relative to assets | Pass | Fail | Pass |
| F-score | — | — | — |
Compare
Put Palatin Technologies side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Palatin Technologies | FY26 | — | −98.2% | −153.8% | — | — | — | |
| Precigen | FY25 | 146.7% | −1,141.1% | −927.6% | — | — | 2 | Compare |
| Coya Therapeutics | FY25 | 123.6% | −283.9% | — | — | — | — | Compare |
| Aclaris Therapeutics | FY25 | −58.2% | −975.9% | −603.4% | — | — | — | Compare |
| Zenas BioPharma | FY25 | 100.0% | −3,830.6% | −1,723.5% | — | — | — | Compare |
10 years of figures
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 67 | 67 | 60 | 0 | −0 | 2 | 5 | 4 | 0 | 9 |
| Revenue growth | — | 0.0% | −10.2% | −99.8% | −259.8% | — | 230.5% | −7.5% | −100.0% | — |
| Gross profit | — | — | — | 0 | −0 | 1 | 4 | 4 | — | — |
| Research and development | 33 | 33 | 15 | 14 | 13 | 21 | 23 | 22 | 15 | 12 |
| Operating income | 26 | 26 | 36 | −24 | −33 | −37 | −32 | −22 | −18 | −9 |
| Net income | 25 | 25 | 36 | −22 | −34 | −36 | −24 | −30 | −17 | −8 |
| Diluted EPS (US$) | 0.01 | 0.01 | 0.01 | −0.01 | −0.01 | — | — | — | −32.15 | −2.96 |
| Diluted shares (millions) | 4,140 | 4,140 | 4,343 | 4,694 | 4,733 | — | 218 | 294 | 0 | 3 |
| Cash flow | ||||||||||
| Cash from operations | 13 | 2 | −22 | 41 | −0 | −30 | −29 | −32 | −21 | −14 |
| Capital expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | 13 | 2 | −22 | 41 | −0 | −30 | −30 | −32 | −21 | −14 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 2 | 4 | 4 | 3 | 3 | 2 | 2 | 2 | 1 | 1 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 40 | 38 | 44 | 83 | 60 | 30 | 14 | 10 | 3 | 8 |
| Debt incl. finance leases | 14 | 6 | 1 | — | — | — | — | — | — | — |
| Total assets | 57 | 39 | 105 | 85 | 67 | 36 | 18 | 11 | 3 | 8 |
| Total liabilities | 62 | 12 | 4 | 5 | 18 | 20 | 20 | 11 | 8 | 2 |
| Shareholders' equity | −5 | 27 | 100 | 80 | 50 | 16 | −2 | −0 | −5 | 7 |
| Margins and ratios | ||||||||||
| Gross margin | — | — | — | 100.0% | 178.4% | 85.2% | 91.4% | 97.8% | — | — |
| Operating margin | 38.6% | 38.6% | 59.3% | −20,007.6% | 17,701.3% | −2,491.6% | −668.8% | −501.0% | — | −98.2% |
| Net margin | 36.8% | 36.8% | 59.3% | −19,006.9% | 17,813.9% | −2,465.1% | −495.2% | −662.3% | — | −94.9% |
| Free cash flow margin | 19.0% | 2.5% | −36.2% | 34,972.4% | 52.7% | −2,055.5% | −612.0% | −701.6% | — | −153.8% |
| Rule of 40 (growth + FCF margin) | — | 2.5% | −46.4% | 34,872.6% | −207.2% | — | −381.5% | −709.1% | — | — |
| Return on capital | — | — | 135.0% | — | — | — | — | — | — | — |
| Return on equity | — | 226.6% | 56.1% | −24.8% | −51.8% | −109.8% | −336.5% | — | — | −877.5% |
| Return on assets | 73.0% | 51.5% | 49.8% | −23.6% | −44.1% | −70.0% | −89.0% | −207.3% | −247.1% | −142.1% |
| Net debt to EBITDA | −1.0x | −1.2x | −1.2x | — | — | — | — | — | — | — |